Clinical trial
The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory…
NCT00437983 · Enzymotec, Industry · Completed
Key facts
| NCT number | NCT00437983 |
|---|---|
| Title | The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment |
| Official title | A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment |
| Lead sponsor | Enzymotec, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Age Associated Memory Impairment |
| Intervention type | Dietary Supplement |
| Interventions | PS-Omega3, Placebo |
| Enrollment | 157 |
| Start date | Apr 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Feb 21, 2007 |
| Last update posted | Jan 5, 2010 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: